PMID: 19142409Jan 15, 2009Paper

Molecular genetic case-control women investigation from the first Brazilian high-risk study on functional psychosis

Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina
Renata KrellingHomero Vallada

Abstract

Data from epidemiological studies have demonstrated that genetics is an important risk factor for psychosis. The present study is part of a larger project, pioneer in Brazil, which has been conducted by other researchers who intend to follow a high-risk population (children) for the development of schizophrenia and bipolar disorder. In this first phase of the project, the objective was to investigate the distribution of four candidate genetic polymorphisms for functional psychosis (Ser9Gly DRD3, 5HTTLPR, the VNTR 3'-UTR SLC6A3 and Val66Met BDNF) in a case-control sample. A total of 105 women (58 with schizophrenia and 47 with bipolar disorder) and 62 gender-matched controls were investigated. Allele and genotype distributions of all identified functional polymorphisms did not differ statistically between cases and controls. These results suggest that the investigated polymorphisms were not related to susceptibility to functional psychoses in our Brazilian sample. These findings need to be validated in larger and independent studies.

References

Feb 11, 1988·Nucleic Acids Research·S A MillerH F Polesky
Jun 1, 1996·Journal of Neurochemistry·A HeilsK P Lesch
Oct 12, 2001·Schizophrenia Research·A LaaksoJ Hietala
Mar 23, 2002·The Pharmacogenomics Journal·S T WeissL J Palmer
Jan 2, 2003·Proceedings of the National Academy of Sciences of the United States of America·Flavia C ParraSérgio D J Pena
Feb 3, 2004·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Ayman H FanousK S Kendler
Apr 20, 2004·Psychiatric Genetics·Erik G JönssonMarc-Antoine Crocq
Jul 5, 2005·European Archives of Psychiatry and Clinical Neuroscience·Wolfgang MaierMarcella Rietschel
Dec 2, 2005·Schizophrenia Bulletin·Nick CraddockMichael J Owen
Mar 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Camila GuindaliniGerome Breen
Apr 11, 2006·Harvard Review of Psychiatry·James B Potash
Apr 28, 2006·American Journal of Human Genetics·Xian-Zhang HuDavid Goldman
Jul 2, 2008·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Elisa Kijner GuttFrancisco Lotufo-Neto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Related Papers

Progress in Neuro-psychopharmacology & Biological Psychiatry
Sheng-Yu LeeRu-Band Lu
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
Wei-wei SunLin He
Progress in Neuro-psychopharmacology & Biological Psychiatry
Paula Suárez-PinillaBenedicto Crespo-Facorro
© 2021 Meta ULC. All rights reserved